Regional Implementation: The Andalusia Initiative
Andalusia has become a pioneer in the regional adoption of liquid biopsy through localized clinical trials and protocols.
NovaSeq Clinical Trial: The region is conducting the first comprehensive clinical trial of Liquid Biopsy using Illumina’s NovaSeq technology across all provinces in Andalusia.
Routine Practice: Recently, Andalusian hospitals (coordinated through centers like GENyO in Granada) successfully implemented ctDNA analysis for metastatic lung cancer into routine clinical practice.
Social Impact: This initiative is designed to provide more accessible and timely diagnosis to populations predisposed to cancer, such as those with hereditary colorectal cancer syndromes.
2 vistas